Skip to main content

Peer Review reports

From: Response to brolucizumab treatment for refractory serous pigment epithelial detachment secondary to polypoidal choroidal vasculopathy

Original Submission
21 Oct 2022 Submitted Original manuscript
31 Oct 2022 Reviewed Reviewer Report
5 Nov 2022 Reviewed Reviewer Report
8 Nov 2022 Author responded Author comments - Mingui Kong
22 Nov 2022 Reviewed Reviewer Report
27 Nov 2022 Reviewed Reviewer Report
Resubmission - Version 2
8 Nov 2022 Submitted Manuscript version 2
Publishing
28 Nov 2022 Editorially accepted
13 Dec 2022 Article published 10.1186/s12886-022-02711-5

You can find further information about peer review here.

Back to article page